Institutional investors purchased a net $2.5 million shares of CCXI during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 55.54% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BVF, INC. Bought 2.4 Million shares of ChemoCentryx Inc
BROADFIN CAPITAL LLC Bought 1.0 Million shares of ChemoCentryx Inc
GREAT POINT PARTNERS LLC Bought 1.0 Million shares of ChemoCentryx Inc